Kangji Medical Holdings Limited (HKG: 9997)

Kangji Medical Holdings Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	980.85	926.02	786.37	690.26	511.49	503.47
Revenue Growth (YoY)	14.37%	17.76%	13.92%	34.95%	1.59%	42.36%
Cost of Revenue	198.28	184.82	151.12	127.34	80.02	80.29
Gross Profit	782.57	741.2	635.25	562.93	431.47	423.18
Selling, General & Admin	182.06	170.11	124.64	108.58	94.58	67
Research & Development	110.83	127.55	66.02	36	25.22	17.38
Operating Expenses	291.47	298.73	189.61	145.19	119.8	84.38
Operating Income	491.1	442.47	445.64	417.74	311.67	338.8
Interest Expense	-1.69	-2.26	-1.88	-0.2	-0.04	-
Interest & Investment Income	111.88	91.89	70	51.59	17.14	16.7
Currency Exchange Gain (Loss)	-26.32	-3.1	-3.2	3.12	-25.04	2.36
Other Non Operating Income (Expenses)	45.48	54.16	53.15	30.78	35.82	33.34
EBT Excluding Unusual Items	614.58	583.16	563.72	503.02	339.55	391.19
Gain (Loss) on Sale of Investments	3.34	5.56	-0.76	31.6	2.94	-
Gain (Loss) on Sale of Assets	27.3	0.05	0.19	-0.12	-0.1	-
Other Unusual Items	-	-	-	-	-32.31	-
Pretax Income	645.22	588.77	563.14	534.5	310.08	391.19
Income Tax Expense	146.54	136.48	101.97	77.71	50.93	64.46
Earnings From Continuing Operations	498.68	452.3	461.17	456.79	259.15	326.74
Minority Interest in Earnings	35.72	51.73	17.56	-	-8.85	-120.29
Net Income	534.41	504.02	478.74	456.79	250.3	206.44
Net Income to Common	534.41	504.02	478.74	456.79	250.3	206.44
Net Income Growth	-7.30%	5.28%	4.80%	82.50%	21.24%	40.72%
Shares Outstanding (Basic)	1,171	1,170	1,208	1,224	953	1,027
Shares Outstanding (Diluted)	1,171	1,172	1,208	1,232	964	1,027
Shares Change (YoY)	-1.32%	-2.95%	-1.95%	27.83%	-6.13%	-
EPS (Basic)	0.46	0.43	0.40	0.37	0.26	0.20
EPS (Diluted)	0.46	0.43	0.40	0.37	0.26	0.20
EPS Growth	-6.04%	8.48%	6.88%	42.78%	29.16%	-
Free Cash Flow	373.29	332.79	243.62	404.88	203.21	316.28
Free Cash Flow Per Share	0.32	0.28	0.20	0.33	0.21	0.31
Dividend Per Share	0.410	0.410	0.184	0.140	0.037	-
Dividend Growth	122.22%	122.22%	31.44%	278.86%	-	-
Gross Margin	79.78%	80.04%	80.78%	81.55%	84.36%	84.05%
Operating Margin	50.07%	47.78%	56.67%	60.52%	60.93%	67.29%
Profit Margin	54.48%	54.43%	60.88%	66.18%	48.93%	41.00%
Free Cash Flow Margin	38.06%	35.94%	30.98%	58.66%	39.73%	62.82%
EBITDA	512.43	464.58	460.32	427.25	319.14	345.2
EBITDA Margin	52.24%	50.17%	58.54%	61.90%	62.39%	68.56%
D&A For EBITDA	21.33	22.11	14.68	9.52	7.47	6.4
EBIT	491.1	442.47	445.64	417.74	311.67	338.8
EBIT Margin	50.07%	47.78%	56.67%	60.52%	60.93%	67.29%
Effective Tax Rate	22.71%	23.18%	18.11%	14.54%	16.42%	16.48%

Source: S&P Capital IQ. Standard template. Financial Sources.